# Varespladib Sodium

National Cancer Institute

## Source

National Cancer Institute. Varespladib Sodium. NCI Thesaurus. Code C73040.

An intravenously administered inhibitor of secretory phospholipase A2 (sPLA2) with orphan drug designation. Varespladib is in trial for prevention of Acute Chest Syndrome in the treatment of sickle cell disease.